Baird, Richard D.; van Rossum, Annelot G.J.; Oliveira, Mafalda; Beelen, Karin; Gao, Meiling; Schrier, Mariette; Mandjes, Ingrid A.M.; Garcia-Corbacho, Javier; Vallier, Anne Laure; Dougall, Greig; van Werkhoven, Erik; Linossi, Constanza; Kumar, Sanjeev; van Tinteren, Harm; Callari, Maurizio; Beddowes, Emma; Perez-Garcia, Jose Manuel; Rosing, Hilde; Platte, Else; Nederlof, Petra; Schot, Margaret; de Vries Schultink, Aurelia; Bernards, Rene; Saura, Cristina; Gallagher, William; Cortes, Javier; Caldas, Carlos; Linn, Sabine C.
(American Association for Cancer Research Inc., 2019-11-15)
Purpose: The strategy of combining endocrine therapy with PI3K-mTOR inhibition has shown promise in estrogen receptor (ER)–positive breast cancer, but new agents and combinations with a better therapeutic index are urgently ...